Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nuance Hearing developed advanced hearing enhancement technology embedded in eyeglasses. Their flagship product—Nuance Audio Glasses—combines prescription-ready eyewear with discreet over-the-counter hearing support for mild to moderate loss. The glasses have received positive lab reviews for speech clarity and comfort but have some limitations such as battery life and lack of streaming features. The technology was acquired by EssilorLuxottica in late 2022 and launched commercially in 2024 under the parent company's brand.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nuance Hearing.